1,632
Views
21
CrossRef citations to date
0
Altmetric
Editorial

Biokinetics of engineered nano-TiO2 in rats administered by different exposure routes: implications for human health

&
Pages 431-433 | Received 09 May 2017, Accepted 11 May 2017, Published online: 19 May 2017

References

  • Baisch BL, Corson NM, Wade-Mercer P, Gelein R, Kennell AJ, Oberdörster G, et al. 2014. Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol 11:5.
  • Couvreur P, Kante B, Grislain L, Roland M, Speiser P. 1982. Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles. J Pharm Sci 71:790–92.
  • DeLoid GM, Cohen JM, Pyrgiotakis G, Demokritou P. 2017. Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials. Nat Protoc 12:355–71.
  • DeLoid GM, Cohen JM, Pyrgiotakis G, Pirela SV, Pal A, Liu J. 2015. Advanced computational modeling for in vitro nanomaterial dosimetry. Part Fibre Toxicol 12:32.
  • Geiser M, Kreyling WG. 2010. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 7:2.
  • Geiser M, Stoeger T, Casaulta M, Chen S, Semmler-Behnke M, Bolle I, et al. 2014. Biokinetics of nanoparticles and susceptibility to particulate exposure in a murine model of cystic fibrosis. Part Fibre Toxicol 11:19.
  • Gregoratto D, Bailey MR, Marsh JW. 2010. Modelling particle retention in the alveolar-interstitial region of the human lungs. J Radiol Prot 30:491–512.
  • Heringa MB, Geraets L, van Eijkeren JC, Vandebriel RJ, de Jong WH, Oomen AG. 2016. Risk assessment of titanium dioxide nanoparticles via oral exposure, including toxicokinetic considerations. Nanotoxicology 10:1515–25.
  • Kreyling WG, Holzwarth U, Haberl N, Kozempel J, Hirn S, Wenk A, et al. 2017a. Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1. Nanotoxicology. [Epub ahead of print]. doi: 10.1080/17435390.2017.1306892
  • Kreyling WG, Holzwarth U, Haberl N, Kozempel J, Wenk A, Hirn S, et al. 2017b. Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3. Nanotoxicology. [Epub ahead of print]. doi: 10.1080/17435390.2017.1306894
  • Kreyling WG, Holzwarth U, Schleh C, Kozempel J, Wenk A, Haberl N, et al. 2017c. Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2. Nanotoxicology. [Epub ahead of print]. doi: 10.1080/17435390.2017.1306893
  • Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health Part A 65:1513–30.
  • Lomer MC, Thompson RP, Commisso J, Keen CL, Powell JJ. 2000. Determination of titanium dioxide in foods using inductively coupled plasma optical emission spectrometry. Analyst 125:2339–2343.
  • Moller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P,. 2008. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 177:426–32.
  • Nel AE. 2013. Implementation of alternative test strategies for the safety assessment of engineered nanomaterials. J Intern Med 274:561–77.
  • Nel A, Xia T, Meng H, , Wang X, Lin S, Ji Z, et al. 2013. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res 46:607–21.
  • Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411–14.
  • Nikula KJ, Avila KJ, Griffith WC, Mauderly JL. 1997. Sites of particle retention and lung tissue responses to chronically inhaled diesel exhaust and coal dust in rats and cynomolgus monkeys. Environ Health Perspect 105:1231–4.
  • Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–39.
  • Pal AK, Bello D, Cohen J, Demokritou P. 2015. Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials. Nanotoxicology 9:871–85.
  • Rompelberg C, Heringa MB, van Donkersgoed G, Drijvers J, Roos A, Westenbrink S, et al. 2016. Oral intake of added titanium dioxide and its nanofraction from food products, food supplements and toothpaste by the dutch population. Nanotoxicology 10:1404–14.
  • Scheuch G, Kohlhaufl M, Moller W, Brand P, Meyer T, Haussinger K, et al. 2008. Particle clearance from the airways of subjects with bronchial hyperresponsiveness and with chronic obstructive pulmonary disease. Exp Lung Res 34:531–49.
  • Silva RM, Doudrick K, Franzi LM, TeeSy C, Anderson DS, Wu Z, et al. 2014. Instillation versus inhalation of multiwalled carbon nanotubes: exposure-related health effects, clearance, and the role of particle characteristics. ACS Nano 8:8911–31.
  • Watson CY, DeLoid GM, Pal A, Demokritou P. 2016. Buoyant nanoparticles: implications for nano-biointeractions in cellular studies. Small 12:3172–80.
  • Weir A, Westerhoff P, Fabricius L, von Goetz N. 2012. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 46:2242–50.
  • Zhang H, Ji Z, Xia T, Meng H, Low-Kam C, Liu R, et al. 2012. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 6:4349–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.